A Phase 1, Single-Center, Randomized, Double-Blind, Placebo-Controlled, Single And Multiple Ascending Dose, First-Time-In-Human Study To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Ecc0509 In Healthy Volunteers
A Phase 1, Single-Center, Randomized, Double-Blind, Placebo-Controlled, Single And Multiple Ascending Dose, First-Time-In-Human Study to Assess The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ECC0509 in Healthy Volunteers.
100 项与 Eccanga Pty Ltd 相关的临床结果
0 项与 Eccanga Pty Ltd 相关的专利(医药)
100 项与 Eccanga Pty Ltd 相关的药物交易
100 项与 Eccanga Pty Ltd 相关的转化医学